MEGAN TIMPONE: Open Payments
NPI 1801324603 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 3 payments from 3 companies in 2025. Trend: 2023 $141 · 2024 $119 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $131 |
| GENZYME CORPORATION | 1 | $128 |
| Medicure Pharma Inc. | 1 | $125 |
Products named: INGREZZA, DUPIXENT, Zypitamag.
Industry payments across GA — which companies pay providers there.
